Advanced search
Publication Cover
Hospital Practice Volume 46, 2018 - Issue 5
Submit an article Journal homepage
172
Views
5
CrossRef citations to date
0
Altmetric
Clinical Focus: Candida and Infectious Diseases - Original Research

Clostridium difficile infection in Johannesburg, South Africa

Lee-Anne GodinhoDepartment of Internal Medicine, Chris Hani Baragwanath Academic Hospital, and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCorrespondence[email protected]
View further author information
&
Charles FeldmanDivision of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, and Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaView further author information
Pages 287-294 | Received 27 Mar 2018, Accepted 04 Oct 2018, Published online: 15 Oct 2018

References

  • Bobo LD, Dubberke ER, Kollef M. Clostridium difficile in the ICU. Chest. 2008;140(6):1643–1650.
  • Rogers MAM, Greene MT, Young VB, et al. Depression, antidepressant medications, and risk of Clostridium difficile infection. BMC Med. 2013;11:121.
  • Collini PJ, Kuijper E, Dockrell H. Clostridium difficile infection in patients with HIV/AIDS. Curr HIV/AIDS Rep. 2013;10:273–283.
  • Mitchell BG, Gardner A. Mortality in Clostridium infection: a review. Antimicrob Resist Infect Control. 2012;1:20.
  • Kutty PK, Woods CW, Sena AC, et al. Risk factors and estimated incidence of community-acquired Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis. 2010;16(2):198–204.
  • Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-acquired Clostridium difficile infection. JAMA Intern Med. 2009;173(14):1359–1367.
  • Leffler DA, Lamonts JT. Clostridium difficile infection. N Eng J Med. 2015;372(16):1539–1548.
  • Gupta K, Khanna S. Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist. 2014;7:63–72.
  • Oake N, Taljaard M, Van Walraven C, et al. The effect of hospital-acquired Clostridium difficile infection on in-hospital mortality. Arch Intern Med. 2010;170(20):1804–1809.
  • Rajabally N, Pentecost M, Pretorius G, et al. The Clostridium difficile problem: a South African tertiary institution’s prospective perspective. S Afr Med J. 2013;103(3):168–172.
  • Keeley AJ, Beeching NJ, Stott KE, et al. Clostridium difficile: a healthcare-associated infection of unknown significance in adults in sub-Saharan Africa. Malawi Med J. 2016;28(2):66–68.
  • Friedman ND, Kaye KS, Stout E, et al. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–797.
  • Cohen SH, Gering DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society For Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–455.
  • Butt E, Foster JAH, Keedwell E, et al. Deviation and validation of simple, accurate and robust prediction rule for the risk of mortality in patient with Clostridium difficile infection. BMC Infect Dis. 2013;13:316.
  • Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478–498.
  • Statistics South Africa. Mid-year population estimates, Statistical release P0302; 2017 [cited 2017 Feb 13]. Available from: http://www.statssa.gov.za/publications/P0302/P03022017.pdf
  • Ogielska M, Lanotte P, Le Brun C, et al. Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literature. Int J Infect Dis. 2015;37:36–41.
  • Lee YM, Huh KC, Yoon SM, et al. Incidence and clinical outcomes of Clostridium difficile infection after treatment with Tuberculosis medication. Gut Liver. 2016;10(2):250–254.
  • Jung SW, Jeon SW, Do BH, et al. Clinical aspects of rifampicin-associated pseudomembranous colitis. J Clin Gastroenterol. 2007;41:38–40.
  • Nakajima A, Yajima S, Shirakura T, et al. Rifampicin-associated pseudomembranous colitis. J Gastroenterol. 2000;35:299–303.
  • Colvin M. Impact of AIDS-the health care burden. In: HIV/AIDS in South Africa. 2nd ed. Cape Town: Cambridge University Press; 2010. p. 359–372.
  • Raines DL, Lopez FA. Clostridium difficile infection in non-HIV-immunocompromised patients and HIV-infected patients. Curr Gastroenterol Rep. 2011;344–350.
  • Stevens VW, Nelson RE, Schwab-Daugherty EM, et al. Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile. JAMA Intern Med. 2017;177(4):546–553.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.